Home/Filings/4/0001358403-18-000072
4//SEC Filing

Smith Alan K. 4

Accession 0001358403-18-000072

CIK 0001358403other

Filed

Jul 4, 8:00 PM ET

Accepted

Jul 5, 4:02 PM ET

Size

5.5 KB

Accession

0001358403-18-000072

Insider Transaction Report

Form 4
Period: 2018-07-02
Smith Alan K.
EVP, Technical Oprations
Transactions
  • Award

    Stock Option (right to buy)

    2018-07-02+39,37539,375 total
    Exercise: $7.72Exp: 2028-07-01Common Stock (39,375 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the stock option vest and become exercisable on January 2, 2019, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.

Issuer

BELLICUM PHARMACEUTICALS, INC

CIK 0001358403

Entity typeother

Related Parties

1
  • filerCIK 0001705246

Filing Metadata

Form type
4
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 4:02 PM ET
Size
5.5 KB